Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas. [electronic resource] by
- Porrata, L F
- Ristow, K
- Witzig, T E
- Tuinistra, N
- Habermann, T M
- Inwards, D J
- Ansell, S M
- Micallef, I N
- Johnston, P B
- Markovic, S N
Producer: 20071227
In:
Leukemia vol. 21
Availability: No items available.
|
|
13.
|
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. [electronic resource] by
- Micallef, I N
- Lillington, D M
- Apostolidis, J
- Amess, J A
- Neat, M
- Matthews, J
- Clark, T
- Foran, J M
- Salam, A
- Lister, T A
- Rohatiner, A Z
Producer: 20000324
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 18
Availability: No items available.
|
|
14.
|
Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma. [electronic resource] by
- Lillington, D M
- Micallef, I N
- Carpenter, E
- Neat, M J
- Amess, J A
- Matthews, J
- Foot, N J
- Young, B D
- Lister, T A
- Rohatiner, A Z
Producer: 20010531
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 19
Availability: No items available.
|
|
15.
|
High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance). [electronic resource] by
- Witzig, T E
- LaPlant, B
- Habermann, T M
- McPhail, E
- Inwards, D J
- Micallef, I N
- Colgan, J P
- Nowakowski, G S
- Ansell, S M
- Johnston, P B
Producer: 20180829
In:
Blood cancer journal vol. 7
Availability: No items available.
|
|
16.
|
Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasia. [electronic resource] by
- Lillington, D M
- Micallef, I N M
- Carpenter, E
- Neat, M J
- Amess, J A L
- Matthews, J
- Foot, N J
- Lister, T A
- Young, B D
- Rohatiner, A Z S
Producer: 20021213
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 13 Suppl 1
Availability: No items available.
|
|
17.
|
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate. [electronic resource] by
- Gertz, M A
- Lacy, M Q
- Dispenzieri, A
- Ansell, S M
- Elliott, M A
- Gastineau, D A
- Inwards, D J
- Micallef, I N M
- Porrata, L F
- Tefferi, A
- Litzow, M R
Producer: 20050505
In:
Bone marrow transplantation vol. 34
Availability: No items available.
|
|
18.
|
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies. [electronic resource] by
- Holtan, S G
- Hogan, W J
- Elliott, M A
- Ansell, S M
- Inwards, D J
- Porrata, L F
- Johnston, P B
- Micallef, I N
- Lacy, M Q
- Gastineau, D A
- Litzow, M R
Producer: 20110531
In:
Bone marrow transplantation vol. 45
Availability: No items available.
|
|
19.
|
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies. [electronic resource] by
- Sinha, S
- Gertz, M A
- Lacy, M Q
- Dispenzieri, A
- Hayman, S R
- Buadi, F K
- Dingli, D
- Micallef, I N
- Hogan, W J
- Gastineau, D A
- Rajkumar, S V
- Kumar, S K
Producer: 20120705
In:
Leukemia vol. 26
Availability: No items available.
|
|
20.
|
A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma. [electronic resource] by
- Crawley, C R
- Foran, J M
- Gupta, R K
- Rohatiner, A Z
- Summers, K
- Matthews, J
- Micallef, I N
- Radford, J A
- Johnson, S A
- Johnson, P W
- Sweetenham, J W
- Lister, T A
Producer: 20010125
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 11
Availability: No items available.
|